The unexpected “New Normal” and “post-COVID-19” era have revolutionized industrial structure and ecosystem.

In order to overcome the risks caused by COVID-19 and maintain continued profit and growth, domestic and foreign companies are examining their business sustainability and accelerating changes in how they work across industries, including how they manage to prepare for disasters (distribution of manpower, diversification of production sites, diversification of supply chains, and untact digital).

The Korean government presented plans to foster the competitiveness and potential in the bio sector as a growth engine in the post-corona industry amid the emergence of digital infrastructure as part of the Korean New Deal policy.

Therefore, it raises questions on preparation for the development of the pharmaceutical/bio/health industries and the global bio-economic era based on fourth industrial technologies such as artificial intelligence and big data.

 

This webinar will introdue some of the latest contributions that artificial intelligence and big data can have on the global bio-economic era.